The 180° spin of meniscal bearing in unicompartmental knee arthroplasty.

Mobile-bearing Oxford medial unicompartmental knee arthroplasty (UKA) has been widely used and has produced good results in the treatment of medial compartmental osteoarthritis. But it is associated with the potential risk of meniscal bearing dislocation. Symptoms caused by most meniscal bearing dislocations include acute pain, knee swelling, and locking. We report two unusual cases of meniscal bearing spinning of 180° without remarkable symptoms, which would have been easily missed if we had not watched carefully. Therefore, if there is sudden locking, pain, swelling, or a slight locking history, the possibility of meniscal bearing spin out as well as meniscal bearing dislocation should be considered and the direction of meniscal bearing markers should be confirmed, especially on lateral radiographs.

Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector.

The 1980s and 1990s saw a major expansion of biotechnology into new areas of science including genomics and recombinant technologies. This was coupled to the widespread emergence of academics into the commercial sector as they were encouraged to spin out companies or commercialize their intellectual property. There were many opportunities to raise investment, and extraordinary success stories were prominent across many areas of technology. The field of plant biotechnology for manufacturing recombinant pharmaceuticals (molecular pharming) emerged and was developed in this period. Like other biotechnologies, this was an exciting new development which offered some very obvious benefits and commercial advantages. In particularly, plant molecular pharming represented a highly novel and potentially disruptive manufacturing technology for recombinant proteins. Twenty-five years on, a series of interviews with senior members of sixteen of the most prominent companies involved in the field provides insight into the original drivers for commercialization, strategic thinking and planning behind key commercial decisions and an insider view into the major reasons for commercial success or failure. These observations and recurring themes identified across a number of commercial ventures remain relevant today, as new biotech companies continue to spin out of the world of academia.

180° rotatory dislocation of the rotating platform of a posterior-stabilized mobile-bearing knee prosthesis; possible complication after closed reduction of a posterior dislocation--a case report.

Dislocation of the rotating platform is a significant early complication of mobile-bearing total knee arthroplasty. The authors report an unusual case of acute 180° rotatory dislocation of the rotating platform after closed reduction of a posterior dislocation of a posterior-stabilized mobile-bearing total knee prosthesis. A 71-year-old male with knee osteoarthritis underwent TKRA using a posterior-stabilized mobile-bearing prosthesis. Posterior dislocation of the prosthesis occurred at 5 weeks postoperatively, and closed reduction of the posterior dislocation resulted in complete 180° rotatory dislocation of the rotating platform. The patient was treated by open exploration and polyethylene exchange for a larger component. This case illustrates that dislocation of a posterior-stabilized mobile-bearing total knee prosthesis can occur given valgus laxity and causes a 90° spin-out of the polyethylene insert, and that closed reduction attempts may contribute to complete 180° rotatory dislocation of the rotating platform. Special attention should be given to both AP and lateral views to ensure that the platform is truly reduced and not rotated by 180°. Plain digital radiography, which enhances the density of polyethylene, or arthrography is helpful for diagnosing this complication.

How academics can make (extra) money out of their science.

This paper analyses how UK academics can make money from their expertise, other than through earning their salary. Using statistics from the success rate and likely remuneration from recent examples, four options are discussed: licensing their intellectual property through their institution's technology transfer office, owning shares in a 'spin-out' company, personal consulting and writing books. The case of the 'average' academic who does not actively pursue any of these goals, the 'active' academic who pursues any one of them, and the top tier academic who is in the top 10 per cent of their profession worldwide are examined. In all cases, consulting is the most economically rewarding option. For the 'average' academic, being involved in a venture-funded start-up is the worst.